LYCOS RETRIEVER 
Arthritis: People
built 634 days ago
![[margin]](http://retrieverimages.lycos.com/images/a/r/t/arthritis/i/039.jpg)
A[R]thritis affects one in six Americans. Although many people think arthritis is an old person’s disease, in fact 3 of every 5 people with arthritis are under age 65. And while many people ... think that arthritis is an inevitable part of aging, in fact arthritis -- the leading cause of disability in the United States -- can be prevented and controlled.
Source:
There are over 140 different types of Arthritis and these can affect people of all ages - from babies and toddlers right through to those in their adult years. In fact, there are over 1000 children and young people under the age of twenty years affected by arthritis in New Zealand at any one time.
Source:
Rheumatoid arthritis usually begins between the ages of 25 to 55 years. More than 85% of patients with rheumatoid arthritis are over the age of 50. Among patients with rheumatoid arthritis, women outnumber men by three to one. In the United States, approximately 1% of the population, or 2.5 million people, have rheumatoid arthritis. It occurs in of all ethnic groups and in all parts of the world. As the population in the developing world ages, and with a rising incidence of the disease, the world market for safe and effective rheumatoid arthritis treatment is projected to reach $6.6 billion annually by the year 2009.
Source:
"Arthritis changes the way individuals complete even the simplest of tasks," says Dany Sfeir, Senior V.P. of Marketing. "Tempur-Pedic is proud that out proprietary TEMPUR® technology helps people with arthritis to rest easy and find relief during the night while still being able to easily use and enjoy the benefits of the mattress."
Source:
Arthritis affects approximately 90% of people over the age of 55 in the United States. It is estimated that by the year 2020, over 60 million people will suffer from this often-disabling problem.
Source:
[S]cientists are looking at new ways to treat rheumatoid arthritis. They are experimenting with new drugs and “biologic agents” that selectively block certain immune system activities associated with inflammation. Recent studies suggest that these represent promising approaches to treatment. Other investigators have shown that minocycline and doxycycline, two antibiotic medications in the tetracycline family, have a modest benefit for people with rheumatoid arthritis.
Source:
MORE ABOUT
People